Eric D. Shaff

President and Chief Executive Officer

CEO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Seres Therapeutics, Inc. (MCRB)	Former President and Chief Executive Officer	$408,333	—	—	$1,338,870	—	$28,346	$1,775,549
2024	Seres Therapeutics, Inc. (MCRB)	President and Chief Executive Officer	$685,000	—	$116,875	$1,459,835	$411,000	$9,297	$2,682,007
2023	Seres Therapeutics, Inc. (MCRB)	President and Chief Executive Officer	$685,000	—	$993,713	$1,140,925	$328,800	$9,898	$3,158,336
2022	Seres Therapeutics, Inc. (MCRB)	President and Chief Executive Officer	$661,600	—	—	$2,938,500	$397,000	$9,148	$4,006,248
2021	Seres Therapeutics, Inc. (MCRB)	President and Chief Executive Officer	$625,400	—	—	$8,758,582	$319,000	$8,698	$9,711,680
2020	Seres Therapeutics, Inc. (MCRB)	President and Chief Executive Officer	$590,000	—	—	$2,050,600	$486,750	$8,550	$3,135,900
2019	Seres Therapeutics, Inc. (MCRB)	President and Chief Executive Officer	$540,000	—	—	$1,231,148	$253,000	$8,400	$2,032,548
2018	Seres Therapeutics, Inc. (MCRB)	President and Chief Executive Officer	$435,000	—	—	$845,520	$158,300	$8,250	$1,447,070

Executive changes

Resigned President and Chief Executive Officer at Seres Therapeutics, Inc. (MCRB)
2025-07-31

Earnings-call appearances

No earnings-call appearances recorded yet.